Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples